BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9987178)

  • 1. Development and in vitro characterization of recombinant vaccinia viruses expressing bovine leukemia virus gp51 in combination with bovine IL4 or IL12.
    Von Beust BR; Brown WC; Estes DM; Zarlenga DS; McElwain TF; Palmer GH
    Vaccine; 1999 Jan; 17(4):384-95. PubMed ID: 9987178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
    Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
    Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
    Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
    J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the bovine leukemia virus envelope glycoprotein (gp51) by recombinant baculovirus and its use in an enzyme-linked immunosorbent assay.
    De Giuseppe A; Feliziani F; Rutili D; De Mia GM
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):147-51. PubMed ID: 14715562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of bovine leukaemia virus envelope gene by recombinant vaccinia viruses.
    Kumar S; Andrew ME; Boyle DB; Brandon RB; Lavin MF; Daniel RC
    Virus Res; 1990 Oct; 17(2):131-42. PubMed ID: 1963249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and immunological characterization of the bovine leukemia virus (BLV) envelope glycoprotein (gp51) produced in Saccharomyces cerevisiae.
    Legrain M; Portetelle D; Dumont J; Burny A; Hilger F
    Gene; 1989 Jul; 79(2):227-37. PubMed ID: 2551774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant viral vaccines for enzootic bovine leucosis.
    Daniel RC; Gatei MH; Good MF; Boyle DB; Lavin MF
    Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():399-404. PubMed ID: 8270269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agar gel immunodiffusion analysis using baculovirus-expressed recombinant bovine leukemia virus envelope glycoprotein (gp51/gp30(T-)).
    Lim SI; Jeong W; Tark DS; Yang DK; Kweon CH
    J Vet Sci; 2009 Dec; 10(4):331-6. PubMed ID: 19934599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of neutralizing antibodies against bovine leukosis virus in rabbits by vaccination with recombinant vaccinia virus expressing bovine leukosis virus envelope glycoprotein.
    Ohishi K; Suzuki H; Maruyama T; Yamamoto T; Funahashi S; Miki K; Ikawa Y; Sugimoto M
    Am J Vet Res; 1990 Aug; 51(8):1170-3. PubMed ID: 2167028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccinia virus: their role in the suppression of BLV replication.
    Ohishi K; Suzuki H; Yasutomi Y; Onuma M; Okada K; Numakunai S; Ohshima K; Ikawa Y; Sugimoto M
    Microbiol Immunol; 1992; 36(12):1317-23. PubMed ID: 1337572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a recombinant vaccinia virus expressing envelope a glycoprotein of bovine leukaemia virus.
    Ohishi K; Maruyama T; Shida H; Nishimaki J; Miki K; Sagata N; Ikawa Y; Sugimoto M
    Vaccine; 1988 Oct; 6(5):428-32. PubMed ID: 2848378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of bovine leukemia virus from Moldovan dairy cattle.
    Pluta A; Rola-Łuszczak M; Kubiś P; Balov S; Moskalik R; Choudhury B; Kuźmak J
    Arch Virol; 2017 Jun; 162(6):1563-1576. PubMed ID: 28213870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient expression of a bovine leukemia virus envelope glycoprotein in plants by a recombinant TBSV vector.
    Zhumabek AT; Abeuova LS; Mukhametzhanov NS; Scholthof HB; Ramankulov YM; Manabayeva SA
    J Virol Methods; 2018 May; 255():1-7. PubMed ID: 29410083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine leukemia virus-gp51 antigen expression is associated with CD5 and IgM markers on infected lymphocytes.
    Meirom R; Moss S; Brenner J
    Vet Immunol Immunopathol; 1997 Oct; 59(1-2):113-9. PubMed ID: 9437829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gammadelta(+) T-Lp6phocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host.
    Lundberg P; Splitter GA
    J Virol; 2000 Sep; 74(18):8299-306. PubMed ID: 10954528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity.
    Ohishi K; Suzuki H; Yamamoto T; Maruyama T; Miki K; Ikawa Y; Numakunai S; Okada K; Ohshima K; Sugimoto M
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1887-92. PubMed ID: 1651982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development.
    Gatei MH; Good MF; Daniel RC; Lavin MF
    J Virol; 1993 Apr; 67(4):1796-802. PubMed ID: 7680386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.
    Bai L; Otsuki H; Sato H; Kohara J; Isogai E; Takeshima SN; Aida Y
    Retrovirology; 2015 Dec; 12():106. PubMed ID: 26715158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenicity of subregions of recombinant bovine leukemia virus (BLV) glycoprotein gp51 for antibody detection.
    Bai L; Soya M; Ichikawa M; Matsuura R; Arimura Y; Wada S; Aida Y
    J Virol Methods; 2023 Jan; 311():114644. PubMed ID: 36332713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to caprine arthritis-encephalitis virus surface protein induced by coimmunization with recombinant vaccinia viruses expressing the caprine arthritis-encephalitis virus envelope gene and caprine interleukin-12.
    Cheevers WP; Hötzel I; Beyer JC; Kumpula-McWhirter N
    Vaccine; 2000 May; 18(23):2494-503. PubMed ID: 10775783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.